TWM
TMO icon

Trueblood Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Trueblood Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$652K Sell
1,301
-196
-13% -$94.1K 0.23% 129
2026
Q1 		$736K Sell
1,497
-25
-2% -$13.6K 0.29% 111
2025
Q4 		$882K Buy
1,522
+2
+0.1% +$1.13K 0.34% 92
2025
Q3 		$737K Sell
1,520
-544
-26% -$253K 0.29% 109
2025
Q2 		$837K Sell
2,064
-129
-6% -$53.9K 0.35% 100
2025
Q1 		$1.09M Hold
2,193
– – 0.51% 62
2024
Q4 		$1.14M Buy
2,193
+57
+3% +$31.3K 0.56% 51
2024
Q3 		$1.32M Sell
2,136
-16
-0.7% -$9.47K 0.66% 40
2024
Q2 		$1.19M Hold
2,152
– – 0.67% 39
2024
Q1 		$1.25M Buy
2,152
+162
+8% +$90.9K 0.72% 38
2023
Q4 		$1.06M Buy
+1,990
New +$963K 0.66% 42

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Trueblood Wealth Management's TMO Position: Q2 2026 in Review

Trueblood Wealth Management reduced its Thermo Fisher Scientific (TMO) stake by 13% in Q2 2026, selling an estimated $94.1K and leaving 1,301 shares worth $652K. The position accounts for 0.23% of the portfolio, ranked #129.

Trueblood Wealth Management first reported a position in TMO in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.32M in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Trueblood Wealth Management held 1,301 shares of Thermo Fisher Scientific worth $652K as of Q2 2026.
  • Trueblood Wealth Management sold 196 Thermo Fisher Scientific shares in Q2 2026, an estimated $94.1K.
  • Thermo Fisher Scientific made up 0.23% of Trueblood Wealth Management's portfolio in Q2 2026, its #129 holding.
  • Trueblood Wealth Management first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 11 quarters since.
  • Trueblood Wealth Management's Thermo Fisher Scientific position peaked at $1.32M in Q3 2024.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Trueblood Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.